Long-term health economic evaluation of intermittently scanned glucose monitoring compared with self-monitoring blood glucose in a real-world setting in Finnish adult individuals with type 1 diabetes

There has been an evolving trend in the use of intermittently scanned continuous glucose monitoring (isCGM) among individuals with type 1 diabetes. Although isCGM is proven to be beneficial in the treatment of individuals with type 1 diabetes, its use leads to increasing device costs. This study aimed to investigate the long-term cost-effectiveness of isCGM.